Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nanog homeobox pseudogene 4 (NANOGP4, also annotated as NANOGP2) is one of several NANOG-derived pseudogenes in the human genome, specifically a processed pseudogene located on chromosome 7p15.1[3]. Unlike the canonical Nanog gene (NANOG), which encodes a crucial homeobox transcription factor involved in embryonic stem cell pluripotency and self-renewal, NANOGP4 does not produce a functional protein and is not believed to serve as a transcription factor or to have a direct biological or disease-related function[3][2][4][5]. The gene is most commonly referenced in genomic surveys and classifications of the homeobox gene family, where it is consistently described as a pseudogene—a segment of DNA resembling a gene, but generally non-functional due to mutations or lack of regulatory elements[3][4]. Alternative names (aliases) include NANOGP2 and Nanog homeobox pseudogene 2, reflecting inconsistent historical nomenclature[3]. In summary, NANOGP4 is not a viable pharmacological or therapeutic target, and should not be confused with functional Nanog paralogs such as NANOG or NANOGP8, which are actively involved in stem cell biology and cancer[1][2][4]. The target you named, "NANOGP4" (also called "NANOGP2"), is not a functional protein or therapeutic target; it is a pseudogene. References to it as a target or candidate for intervention in biological or disease processes are incorrect[3][4]. The only functional human *Nanog*-related transcription factors are encoded by NANOG and possibly by NANOGP8 in certain cancers[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nanog homeobox pseudogene 4 (NANOGP4).